ReginaRestaMD

Oncology • Troy, NY

Physician

Join to view full profile

Dr. Resta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Resta's full profile

Already have an account?

Office
258 Hoosick St, Ste 206
NYOH
Troy, NY 12180
Phone+1 518-272-2097

Fax+1 518-272-6612
Is this information wrong?

Education & Training

University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1988 - 1991
University of Pennsylvania Health SystemResidency, Internal Medicine, 1985 - 1988
Washington University in St. Louis School of MedicineClass of 1985

Certifications & Licensure

NY State Medical License 1997 - 2025
OK State Medical License 1991 - 2009
PA State Medical License 1986 - 2002
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

518 Life Magazine Castle Connolly, 2014
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Hudson Valley Magazine Castle Connolly, 2006-2007

Clinical Trials

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer Start of enrollment: 2012 Apr 01
Terminated
Phase 2
BKM120 for Patients With PI3K-activated Tumors Start of enrollment: 2013 Mar 29
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

13 citations
Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer.
Sakti Chakrabarti, Leslie Bucheit, Jason Scott Starr, Racquel Innis-Shelton, Ardaman Shergill, Hiba Dada, Regina Resta, Stephanie Wagner, Naomi Fei, Pashtoon Murtaza Kasi> ;Journal for Immunotherapy of Cancer. 2022 Jun 1
17 citations
Incidence and Predictive Factors for Recovery of Ovarian Function in Amenorrheic Women in Their 40s Treated With Letrozole
Lea Krekow, Beth A. Hellerstedt, Rufus P. Collea, Steven Papish, Shrinivas M. Diggikar, Regina Resta, Svetislava J. Vukelja, Frankie A. Holmes, Praveen K. Reddy, Lina ...> ;Journal of Clinical Oncology. 2016 Sep 27
24 citations
Light chain proximal tubulopathy
Leal Herlitz, Joseph Roglieri, Regina Resta, Govind Bhagat, Glen S. Markowitz> ;Kidney International. 2009 Oct 1
459 citations
Crucial Role for Ecto-5′-Nucleotidase (CD73) in Vascular Leakage during Hypoxia
Linda F. Thompson, Holger K. Eltzschig, Juan C. Ibla, C. Justin Van De Wiele, Regina Resta, Julio C. Morote-Garcia, Sean P. Colgan> ;The Journal of Experimental Medicine. 2004 Dec 6
61 citations
Single nucleotide polymorphism in prohibitin 3' untranslated region and breast-cancer susceptibility.
Eldon R. Jupe, Allen A Badgett, Barbara R. Neas, Melissa A Craft, Debra S. Mitchell, Regina Resta, John J. Mulvihill, Christopher E. Aston, Linda F. Thompson> ;Lancet. 2001 May 19
30 citations
Metabolites from apoptotic thymocytes inhibit thymopoiesis in adenosine deaminase-deficient fetal thymic organ cultures
Linda F. Thompson, C. Justin Van De Wiele, Aletha B. Laurent, Scott W. Hooker, James G. Vaughn, Hong Jiang, Kamayani Khare, Rodney E. Kellems, Michael R. Blackburn, Mi...> ;The Journal of Clinical Investigation. 2000 Nov 1
50 citations
CD73 expression and fyn‐dependent signaling on murine lymphocytes
Yoshio Yamashita, Scott W. Hooker, Hong Jiang, Aletha B. Laurent, Regina Resta, Kamayani Khare, Andrew J. Coe, Paul W. Kincade, Linda F. Thompson> ;European Journal of Immunology. 1998 Oct 1
259 citations
Ecto‐enzyme and signaling functions of lymphocyte CD 7 3
Regina Resta, Yoshio Yamashita, Linda F. Thompson> ;Immunological Reviews. 1998 Feb 1
Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides.
Morabito L, Montesinos MC, Schreibman DM, Balter L, Thompson LF, Resta R, Carlin G, Huie MA, Cronstein BN> ;J. Clin. Invest.. 1998-01-15
3 citations
Insights into adenosine deaminase deficiency provided by murine fetal thymic organ culture with 2'-deoxycoformycin.
Regina Resta, Hong Jiang, Scott W. Hooker, Aletha B. Laurent, Linda F. Thompson> ;Advances in Experimental Medicine and Biology. 1998 Jan 1
54 citations
SCID: The role of adenosine deaminase deficiency
Regina Resta, Linda F. Thompson> ;Immunology Today. 1997 Aug 1
8 citations
REASSESSMENT OF GERMLINE HEAVY CHAIN TRANSCRIPTS FROM TWO MURINE VH FAMILIES
Carol F. Webb, Shenshen Dou, Kent L. Buchanan, Regina Resta, Glennda Smithson, Elizabeth A. Smith> ;Molecular Immunology. 1997 Jul 1
32 citations
Insights into thymic purine metabolism and adenosine deaminase deficiency revealed by transgenic mice overexpressing ecto-5'-nucleotidase (CD73).
Regina Resta, Scott W. Hooker, Aletha B. Laurent, S. M. Jamshedur Rahman, M Franklin, Thomas B. Knudsen, N L Nadon, Linda F. Thompson> ;The Journal of Clinical Investigation. 1997 Feb 15
44 citations
T cell signalling through CD73.
Regina Resta, Linda F. Thompson> ;Cellular Signalling. 1997 Feb 1
42 citations
Isolation and characterization of the promoter of the human 5′-nucleotidase (CD73)-encoding gene
Karl R. Hansen, Regina Resta, Carol F. Webb, Linda F. Thompson> ;Gene. 1995 Dec 29
52 citations
Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor.
N K Puffinbarger, Karl R. Hansen, Regina Resta, Aletha B. Laurent, Thomas B. Knudsen, J L Madara, Linda F. Thompson> ;Molecular Pharmacology. 1995 Jun 1
28 citations
Ecto-5'-nucleotidase activity is not required for T cell activation through CD73.
Wolf Gutensohn, Regina Resta, Yoshio Misumi, Yukio Ikehara, Linda F. Thompson> ;Cellular Immunology. 1995 Apr 1
2 citations
Ecto-5’-Nucleotidase (CD73): Genomic Cloning and Characterization of Regions Upstream of the Translation Start Site
Karl R. Hansen, Regina Resta, Carol F. Webb, Linda F. Thompson> ;Advances in Experimental Medicine and Biology. 1995 Jan 1
32 citations
Glycosyl phosphatidylinositol membrane anchor is not required for T cell activation through CD73.
Regina Resta, Scott W. Hooker, Aletha B. Laurent, J K Shuck, Y Misumi, Y Ikehara, Gary A. Koretzky, Linda F. Thompson> ;Journal of Immunology. 1994 Aug 1
62 citations
Murine ecto-5'-nucleotidase (CD73): cDNA cloning and tissue distribution
Regina Resta, Scott W. Hooker, Karl R. Hansen, Aletha B. Laurent, J. L. Park, Michael R. Blackburn, Thomas B. Knudsen, Linda F. Thompson> ;Gene. 1993 Nov 15
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

ReginaRestaMD

Dr. Resta is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.